Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

sirolimus-loaded polymeric nanoparticles

Based on

1 Patents
2013 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

poly(ethylene glycol)-block-polylactide copolymer

PLA-PEG
Type Polymer
Formula
Role binder
2

rapamycin

sirolimus
Type Single Compound
Formula C51H79NO13
Role fillers

Properties

General physical and chemical properties

Property Value Source
drug release

0 more entry available to subscribes only.

Or, view sample content

Applications

Area Application Source
drug delivery

0 more entry available to subscribes only.

Or, view sample content

Characterization

Method Source
dynamic light scattering

0 more entry available to subscribes only.

Or, view sample content

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • poly(ethylene glycol)-block-polylactide copolymer
  • rapamycin
  1. qiYvhLRgoRdHEcmwvqAaVB5sYzyDlx2SgicJsENk0TJOhiKwBnvDQoguWT
  2. 98Z7rBOdy2WTVKj
Product

sirolimus-loaded polymeric nanoparticles

Method 2

Type: Physical formation
Source:
Starting materials
  • poly(ethylene glycol)-block-polylactide copolymer
  • rapamycin
  1. VYJh1W5d9BpcF7QFvPaxuHLHzLiaIf2xcgOQ4uYzABwgUR1ol9mxsxbUNG
  2. XNH5onu2Rzg9gu7
Product

sirolimus-loaded polymeric nanoparticles

Method 3

Type: Physical formation
Source:
Starting materials
  • poly(ethylene glycol)-block-polylactide copolymer
  • rapamycin
  1. SWNf2LsrelQ8fxla1lbpGo4aqGOZ4ksLPZhTJVRwvhB4OwampacISPCfJM
  2. XbB6dJ7w6IQaFK5
Product

sirolimus-loaded polymeric nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial